CLINICAL_TRIALS ClinicalTrials.gov record update

A Randomized, Double-blind Trial to Evaluate the Efficacy, Safety and Immunogenicity of MSB11022 Compared With Humira® in Subjects With Moderate to Severe Chronic Plaque Psoriasis

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT02660580
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:39:24.033154+00:00
Published At: 2019-02-19T00:00:00+00:00
Record Updated At: 2023-12-27
Results Posted At: 2019-02-19
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Psoriasis", "Plaque Type Psoriasis", "Moderate to Severe Plaque Psoriasis"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2023-12-27"
protocolSection.identificationModule.nctId: "NCT02660580"
protocolSection.identificationModule.officialTitle: "A Randomized, Double-blind Trial to Evaluate the Efficacy, Safety and Immunogenicity of MSB11022 Compared With Humira\u00ae in Subjects With Moderate to Severe Chronic Plaque Psoriasis"
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: ["PHASE3"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: "2019-02-19"

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.